Invest in France Agency nordic-countries Office

The cluster has two main goals :

• Contribute to innovation in the fields of prevention, diagnosis and treatment of cancer, and create new high added-value resources in particular by contributing to the development of an internationally recognized benchmark biocluster, dedicated to cancer : Toulouse Cancer Campus.
• Offer a human and public healthcare solution by developing an organizational model that can be adapted to other major groups of chronic diseases

Advantages

The Cancer-Bio-Santé cluster is supported by one of the most extensive networks of private companies, research and education in Europe

Companies and jobs More than 200 companies
More than 30,000 jobs   

Research 3,650 research scientists :  2,000 in the public sector and 1,650 in the private sector
Education Toulouse Cancer Campus, a public-private enterprise representing over one billion euros
110,000 students making it the second leading university cluster in France

Founder member of the Life Science Corridor France
•    Strategic partnerships with 2 other clusters : Lyon Biopole and Alsace Biovalley
•    The goal is to support SME’s in the international market and set up international partnerships based around specific collaborative projects

Partners

Moe than 130 members as at June 2008

Companies  105   
•    French groups: Laboratoires Pierre Fabre, Sanofi-Aventis,  Thalès,  Communication et Systèmes…           
•    International groups: GlaxoSmithKline (United Kingdom), IBM (United States), Siemens (Germany), Lallemand (Canada)…

72 SME’s 

Research and educational establishments
More than 20 including the Toulouse University, Institut National Polytechnique de Toulouse (INPT), Centre National de la Recherche Scientifique (CNRS), Ecole des Mines d’Albi-Carmaux, Centres Hospitaliers Universitaires (CHU) de Toulouse et Limoges, Ecole Nationale Vétérinaire de Toulouse (ENVT), Génopole, Ecole Supérieure de Commerce de Toulouse (ESCT)…
   
Approximately 10 other organizations are also stakeholders in the cluster including the Limousin and Midi-Pyrénées Regional Councils, Communautés d’Agglomération du Grand Toulouse, de Castres-Mazamet et le Sicoval, Midi Biotech, le SISMIP, Midi Pyrénées Expansion, Limousin Expansion, Ariège Expansion...,

Current R&D partnerships

31 projects had been approved and funded at the end of 2007, representing a total  investment of more than 12 million euros

Example of public funding :
•    Approximately 6 million euros awarded by the Inter-ministerial Single Fund (FUI)

International partnerships

Current
•    Partnership in the Life Science Corridor France with the Kansai BioPromotion Council, cluster between Osaka and Kyoto, Japan, the Boston biocluster and the Quebec biocluster, as part of the Life Science Corridor France
•    Proposed participation in the European SUDOE program : Intereg with Portugal (Lisbon) and Spain (Valencia and Barcelona)
•    Proposed participation in the Bio-EurobioRegion meeting between 5 French and Spanish regions

Future
•    Making SME’s more sensitive to the international environment via the Research and Development Framework Program (PCRD)

• More information on Cancer Bio Santé cluster